Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Real-World Experience Using Tafasitamab Plus Lenalidomide and/or Loncastuximab Tesirine in a Predominately Hispanic Population with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Heidi Latiolais, Justin Horowitz, Joel Michalek, Adolfo Enrique Diaz Duque

Blood (2024) 144 (Supplement 1): 7780.

https://doi.org/10.1182/blood-2024-207515

Published: 2024

Journal Articles

Disparities in Clinical Outcomes of B-Lymphoblastic Lymphoma: A National Cancer Database Study with Focus on Hispanic Populations in the United States

Daniela Urueta Portillo, Ian Mines, Qianqian Liu, Joel Michalek, Adolfo Enrique Diaz Duque

Blood (2023) 142 (Supplement 1): 3120.

https://doi.org/10.1182/blood-2023-189943

Published: 2023

Journal Articles

Racial and Ethnic Disparities for Primary CNS Lymphoma: A National Cancer Database Analysis with Emphasis on Hispanics

Daniel Rosas, Esteban Toro Velez, Carolina Velez-Mejia, Qianqian Liu, Joel Michalek, Adolfo Enrique Diaz Duque

Blood (2023) 142 (Supplement 1): 4508.

https://doi.org/10.1182/blood-2023-184982

Published: 2023

Journal Articles

Venetoclax for Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis of Clinical Outcomes

Jay Parekh, Soniya Abraham, Karthik Chamarti, Yaw Adjepong, Adolfo Enrique Diaz Duque

Blood (2023) 142 (Supplement 1): 6142.

https://doi.org/10.1182/blood-2023-187878

Published: 2023

Journal Articles

A National Cancer Database Analysis of Demographics, Treatment Patterns and Survival Trends of Patients with Plasmablastic Lymphoma in US: Does Ethnicity Predict Enhanced Outcomes?

Heidi Latiolais, Qianqian Liu, Joel Michalek, Adolfo Enrique Diaz Duque

Blood (2023) 142 (Supplement 1): 1774.

https://doi.org/10.1182/blood-2023-187774

Published: 2023

Journal Articles

Breaking Barriers in Classic Hodgkin Lymphoma: Unraveling Disparities between Hispanic and Non-Hispanic Patients Via the National Cancer Database (NCDB)

Daniela Urueta Portillo, Supreet Kaur, Qianqian Liu, Joel Michalek, Adolfo Enrique Diaz Duque

Blood (2023) 142 (Supplement 1): 4449.

https://doi.org/10.1182/blood-2023-189768

Published: 2023

Journal Articles

Demographics and Survival Outcomes of Burkitt Lymphoma in the US: A Hospital-Based Study from the National Cancer Database with Focus on Hispanics

Sergio A. Vallejo, Victor Ramon Mendiola, Joel Michalek, Qianquian Liu, Adolfo Enrique Diaz Duque

Blood (2023) 142 (Supplement 1): 3117.

https://doi.org/10.1182/blood-2023-187823

Published: 2023

Journal Articles

Racial and Ethnic Disparities for Diffuse Large B-Cell Lymphoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis with Emphasis on Hispanics

Daniel Rosas, Esteban Toro Velez, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2022) 140 (Supplement 1): 6695–6696.

https://doi.org/10.1182/blood-2022-159201

Published: 2022

Journal Articles

Demographics, Analysis of Survival and Outcomes of Primary Effusion Lymphomas: A National Retrospective Study with a Focus on Hispanics

Gabriel Roman Souza, Katherine Thiel, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2022) 140 (Supplement 1): 6670–6671.

https://doi.org/10.1182/blood-2022-158719

Published: 2022

Journal Articles

Current Status of Demographics and Survival Outcomes of Cutaneous T-Cell Lymphoma - Not Otherwise Specified in United States: A Contemporary Population Based Study with Focus on Hispanics

Esteban Toro Velez, Lauren Diaz Boyle, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2022) 140 (Supplement 1): 10953–10954.

https://doi.org/10.1182/blood-2022-170329

Published: 2022

Journal Articles

Current Status of Racial and Ethnic Disparities for Follicular Lymphoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis with Emphasis on Hispanics

Daniel Rosas, Daniela Urueta, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2022) 140 (Supplement 1): 6522–6523.

https://doi.org/10.1182/blood-2022-159163

Published: 2022

Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo Enrique Diaz Duque, Anand Karnad, Matthew James Butler, Elizabeth Bowhay-Carnes, Joel E Michalek, Gabriela Huelgas, Ricardo Aguiar

Blood (2022) 140 (Supplement 1): 6610–6611.

https://doi.org/10.1182/blood-2022-167001

Published: 2022

Journal Articles

Identifying Demographic and Disease Related Differences in Hispanic Vs Non-Hispanic Patients with Post Transplant Lymphoproliferative Disorders

Supreet Kaur, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2022) 140 (Supplement 1): 3798–3799.

https://doi.org/10.1182/blood-2022-168259

Published: 2022

Journal Articles

Post-Transplant Lymphoproliferative Disorder after Solid Organ Transplant: From Epidemiology to Survival Outcomes from 2000 - 2022

Supreet Kaur, Pankil Shah, Adolfo Enrique Diaz Duque, Dimpy P. Shah

Blood (2022) 140 (Supplement 1): 1074–1075.

https://doi.org/10.1182/blood-2022-170919

Published: 2022

Journal Articles

Identifying Demographic and Disease Related Differences in Hispanic Vs Non-Hispanic Patients with Classical Hodgkin Lymphoma

Abhishek Pandya, Supreet Kaur, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2022) 140 (Supplement 1): 13186–13188.

https://doi.org/10.1182/blood-2022-170870

Published: 2022

Journal Articles

Understanding Oncological Disparities in Mycosis Fungoides within Hispanic Enriched Communities

Rodolfo Garza-Morales, Carolina Velez-Mejia, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2021) 138 (Supplement 1): 5016.

https://doi.org/10.1182/blood-2021-151891

Published: 2021

Journal Articles

Insurance Is No Longer a Determinant to Improve Overall Survival for Patients Diagnosed with HL, DLBCL or PCNS in an Enriched Hispanic Community

Carolina Velez-Mejia, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2021) 138 (Supplement 1): 1974.

https://doi.org/10.1182/blood-2021-151816

Published: 2021

Journal Articles

Ethnicity, Nativity and Outcomes in Burkitt Lymphoma Among US Hispanics: Texas and Florida State Database Study

Snegha Ananth, Ysaith Efren Orellana, Joel E Michalek, Qianqian Liu, Adolfo Enrique Diaz Duque

Blood (2021) 138 (Supplement 1): 4087.

https://doi.org/10.1182/blood-2021-149981

Published: 2021

Journal Articles

Disparities in Mantle Cell Lymphoma Outcomes in Hispanics: A Population Based Analysis in Texas and Florida

Brian Warnecke, Daniel Rosas, Alexandra Wehbe, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2021) 138 (Supplement 1): 4081.

https://doi.org/10.1182/blood-2021-145937

Published: 2021

Journal Articles

Population-Based Analysis of Hispanic Vs Non-Hispanic Patients Diagnosed with Hodgkin Lymphoma in Texas and Florida

Abhishek Pandya, Munaf Al-Kadhimi, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque

Blood (2021) 138 (Supplement 1): 4531.

https://doi.org/10.1182/blood-2021-152695

Published: 2021

NARROW

Real-World Experience Using Tafasitamab Plus Lenalidomide and/or Loncastuximab Tesirine in a Predominately Hispanic Population with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Disparities in Clinical Outcomes of B-Lymphoblastic Lymphoma: A National Cancer Database Study with Focus on Hispanic Populations in the United States

Racial and Ethnic Disparities for Primary CNS Lymphoma: A National Cancer Database Analysis with Emphasis on Hispanics

Venetoclax for Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis of Clinical Outcomes

A National Cancer Database Analysis of Demographics, Treatment Patterns and Survival Trends of Patients with Plasmablastic Lymphoma in US: Does Ethnicity Predict Enhanced Outcomes?

Breaking Barriers in Classic Hodgkin Lymphoma: Unraveling Disparities between Hispanic and Non-Hispanic Patients Via the National Cancer Database (NCDB)

Demographics and Survival Outcomes of Burkitt Lymphoma in the US: A Hospital-Based Study from the National Cancer Database with Focus on Hispanics

Racial and Ethnic Disparities for Diffuse Large B-Cell Lymphoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis with Emphasis on Hispanics

Demographics, Analysis of Survival and Outcomes of Primary Effusion Lymphomas: A National Retrospective Study with a Focus on Hispanics

Current Status of Demographics and Survival Outcomes of Cutaneous T-Cell Lymphoma - Not Otherwise Specified in United States: A Contemporary Population Based Study with Focus on Hispanics

Current Status of Racial and Ethnic Disparities for Follicular Lymphoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis with Emphasis on Hispanics

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Identifying Demographic and Disease Related Differences in Hispanic Vs Non-Hispanic Patients with Post Transplant Lymphoproliferative Disorders

Post-Transplant Lymphoproliferative Disorder after Solid Organ Transplant: From Epidemiology to Survival Outcomes from 2000 - 2022

Identifying Demographic and Disease Related Differences in Hispanic Vs Non-Hispanic Patients with Classical Hodgkin Lymphoma

Understanding Oncological Disparities in Mycosis Fungoides within Hispanic Enriched Communities

Insurance Is No Longer a Determinant to Improve Overall Survival for Patients Diagnosed with HL, DLBCL or PCNS in an Enriched Hispanic Community

Ethnicity, Nativity and Outcomes in Burkitt Lymphoma Among US Hispanics: Texas and Florida State Database Study

Disparities in Mantle Cell Lymphoma Outcomes in Hispanics: A Population Based Analysis in Texas and Florida

Population-Based Analysis of Hispanic Vs Non-Hispanic Patients Diagnosed with Hodgkin Lymphoma in Texas and Florida

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only